Health
STEP 4: Significant weight loss maintained with weekly semaglutide – Healio
Adults with obesity who continued once-weekly semaglutide therapy beyond 20 weeks saw continued weight loss or weight maintenance compared with adults who were…
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected] to Healio
Adults with obesity who continued once-weekly semaglutide therapy beyond 20 weeks saw continued weight loss or weight maintenance compared with adults who were switched to placebo, data from the STEP 4 study show.
“The message here is twofold. One, for the patient and the doctor, there is hope for the medical treatment of obesity,” Domenica…
-
Noosa News24 hours agoAustralian growers expect to benefit from US tariffs as Trump’s trade war angers markets
-
Noosa News23 hours agoHow to get the most from potted citrus and when they’ll fruit
-
General23 hours agoPeter Dutton partially walks back public service work-from-home vow
-
Noosa News21 hours agoDisaster relief packages announced for flood-stricken western Queensland